Xolalpa W - Search Results

1

Breaking Bad Proteins-Discovery Approaches and the Road to Clinic for Degraders.

Bouvier C, Lawrence R, Cavallo F, Xolalpa W, Jordan A, Hjerpe R, Rodriguez MS. Bouvier C, et al. Among authors: xolalpa w. Cells. 2024 Mar 26;13(7):578. doi: 10.3390/cells13070578. Cells. 2024. PMID: 38607017 Free PMC article. Review.

2

Ubiquitin-chains dynamics and its role regulating crucial cellular processes.

Gonzalez-Santamarta M, Bouvier C, Rodriguez MS, Xolalpa W. Gonzalez-Santamarta M, et al. Among authors: xolalpa w. Semin Cell Dev Biol. 2022 Dec;132:155-170. doi: 10.1016/j.semcdb.2021.11.023. Epub 2021 Dec 9. Semin Cell Dev Biol. 2022. PMID: 34895814 Free article. Review.

3

Real-Time Surface Plasmon Resonance (SPR) for the Analysis of Interactions Between SUMO Traps and Mono- or PolySUMO Moieties.

Xolalpa W, Rodriguez MS, England P. Xolalpa W, et al. Methods Mol Biol. 2016;1475:99-107. doi: 10.1007/978-1-4939-6358-4_7. Methods Mol Biol. 2016. PMID: 27631800

4

Isolation of the Ubiquitin-Proteome from Tumor Cell Lines and Primary Cells Using TUBEs.

Xolalpa W, Mata-Cantero L, Aillet F, Rodriguez MS. Xolalpa W, et al. Methods Mol Biol. 2016;1449:161-75. doi: 10.1007/978-1-4939-3756-1_8. Methods Mol Biol. 2016. PMID: 27613034

5

Targeting the ubiquitin proteasome system: beyond proteasome inhibition.

Xolalpa W, Perez-Galan P, Rodríguez MS, Roué G. Xolalpa W, et al. Curr Pharm Des. 2013;19(22):4053-93. doi: 10.2174/1381612811319220014. Curr Pharm Des. 2013. PMID: 23181575 Review.

6

Analysis of defective protein ubiquitylation associated to adriamycin resistant cells.

Lang V, Aillet F, Xolalpa W, Serna S, Ceccato L, Lopez-Reyes RG, Lopez-Mato MP, Januchowski R, Reichardt NC, Rodriguez MS. Lang V, et al. Among authors: xolalpa w. Cell Cycle. 2017;16(24):2337-2344. doi: 10.1080/15384101.2017.1387694. Epub 2017 Nov 20. Cell Cycle. 2017. PMID: 29099265 Free PMC article.

7

Analysis of PTEN ubiquitylation and SUMOylation using molecular traps.

Lang V, Aillet F, Da Silva-Ferrada E, Xolalpa W, Zabaleta L, Rivas C, Rodriguez MS. Lang V, et al. Among authors: xolalpa w. Methods. 2015 May;77-78:112-8. doi: 10.1016/j.ymeth.2014.09.001. Epub 2014 Sep 16. Methods. 2015. PMID: 25224693

8

A comprehensive platform for the analysis of ubiquitin-like protein modifications using in vivo biotinylation.

Pirone L, Xolalpa W, Sigurðsson JO, Ramirez J, Pérez C, González M, de Sabando AR, Elortza F, Rodriguez MS, Mayor U, Olsen JV, Barrio R, Sutherland JD. Pirone L, et al. Among authors: xolalpa w. Sci Rep. 2017 Jan 18;7:40756. doi: 10.1038/srep40756. Sci Rep. 2017. PMID: 28098257 Free PMC article.

9

Constitutive Activation of p62/Sequestosome-1-Mediated Proteaphagy Regulates Proteolysis and Impairs Cell Death in Bortezomib-Resistant Mantle Cell Lymphoma.

Quinet G, Xolalpa W, Reyes-Garau D, Profitós-Pelejà N, Azkargorta M, Ceccato L, Gonzalez-Santamarta M, Marsal M, Andilla J, Aillet F, Bosch F, Elortza F, Loza-Alvarez P, Sola B, Coux O, Matthiesen R, Roué G, Rodriguez MS. Quinet G, et al. Among authors: xolalpa w. Cancers (Basel). 2022 Feb 12;14(4):923. doi: 10.3390/cancers14040923. Cancers (Basel). 2022. PMID: 35205670 Free PMC article.

10

Development of two novel high-throughput assays to quantify ubiquitylated proteins in cell lysates: application to screening of new anti-malarials.

Mata-Cantero L, Cid C, Gomez-Lorenzo MG, Xolalpa W, Aillet F, Martín JJ, Rodriguez MS. Mata-Cantero L, et al. Among authors: xolalpa w. Malar J. 2015 May 14;14:200. doi: 10.1186/s12936-015-0708-1. Malar J. 2015. PMID: 25968882 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page